Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be ...

The European Commission approved Tevimbra, the commercial name for Tislelizumab, in combination with chemotherapy for the first-line treatment of esophageal squamous cell carcinoma and gastric or ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

Shares of BeiGene rose Wednesday morning after the company said it has received regulatory approval for its treatment of gastric and esophageal cancers from the European Union. Shares were recently up ...

Combination of radiation, chemotherapy and immunotherapy can shrink tumors and allow surgery, with much better survival rate.

BeiGene ($BGNE) shares jumped over 5% pre-market Wednesday, with the oncology company’s stock poised to reach a two-week high ...

Across the world, people love drinking endless cups of tea and coffee – that of piping. And now that cold weather is here, ...

The EC considered the treatment's activity in patients with advanced, PD-L1-positive esophageal and gastric cancers in the RATIONALE-305 and -306 trials.

For patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) and then surgery is promising.

Uruguay's cult ex-president Jose Mujica -- a leftist icon for his humble lifestyle and progressive policies -- warned in an ...